Literature DB >> 24675518

RHOA mutations in peripheral T cell lymphoma.

Jan Cools1.   

Abstract

Peripheral T cell lymphomas are rare but aggressive non-Hodgkin lymphomas derived from mature T lymphocytes or natural killer (NK) cells. New studies identify recurrent dominant-negative mutation of the RHOA GTPase gene in these lymphomas.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24675518     DOI： 10.1038/ng.2937

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


  14 in total

1.  Loss of Rho function in the thymus is accompanied by the development of thymic lymphoma.

Authors:  S C Cleverley; P S Costello; S W Henning; D A Cantrell
Journal:  Oncogene       Date:  2000-01-06       Impact factor: 9.867

2.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.

Authors:  Cyril Quivoron; Lucile Couronné; Véronique Della Valle; Cécile K Lopez; Isabelle Plo; Orianne Wagner-Ballon; Marcio Do Cruzeiro; Francois Delhommeau; Bertrand Arnulf; Marc-Henri Stern; Lucy Godley; Paule Opolon; Hervé Tilly; Eric Solary; Yannis Duffourd; Philippe Dessen; Hélène Merle-Beral; Florence Nguyen-Khac; Michaëla Fontenay; William Vainchenker; Christian Bastard; Thomas Mercher; Olivier A Bernard
Journal:  Cancer Cell       Date:  2011-06-30       Impact factor: 31.743

3.  Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.

Authors:  Ghee Chong Koo; Soo Yong Tan; Tiffany Tang; Song Ling Poon; George E Allen; Leonard Tan; Soo Ching Chong; Whee Sze Ong; Kevin Tay; Miriam Tao; Richard Quek; Susan Loong; Kheng-Wei Yeoh; Swee Peng Yap; Kuo Ann Lee; Lay Cheng Lim; Daryl Tan; Christopher Goh; Ioana Cutcutache; Willie Yu; Cedric Chuan Young Ng; Vikneswari Rajasegaran; Hong Lee Heng; Anna Gan; Choon Kiat Ong; Steve Rozen; Patrick Tan; Bin Tean Teh; Soon Thye Lim
Journal:  Cancer Discov       Date:  2012-06-15       Impact factor: 39.397

Review 4.  The role of mutations in epigenetic regulators in myeloid malignancies.

Authors:  Alan H Shih; Omar Abdel-Wahab; Jay P Patel; Ross L Levine
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

Review 5.  Molecular genetics of peripheral T-cell lymphomas.

Authors:  Pier Paolo Piccaluga; Valentina Tabanelli; Stefano A Pileri
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

6.  Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1.

Authors:  S Zhang; J Han; M A Sells; J Chernoff; U G Knaus; R J Ulevitch; G M Bokoch
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

7.  CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.

Authors:  Bettina Bisig; Aurélien de Reyniès; Christophe Bonnet; Pierre Sujobert; David S Rickman; Teresa Marafioti; Georges Delsol; Laurence Lamant; Philippe Gaulard; Laurence de Leval
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

Review 8.  Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology.

Authors:  Bengt Hallberg; Ruth H Palmer
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

9.  Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.

Authors:  Mamiko Sakata-Yanagimoto; Terukazu Enami; Kenichi Yoshida; Yuichi Shiraishi; Ryohei Ishii; Yasuyuki Miyake; Hideharu Muto; Naoko Tsuyama; Aiko Sato-Otsubo; Yusuke Okuno; Seiji Sakata; Yuhei Kamada; Rie Nakamoto-Matsubara; Nguyen Bich Tran; Koji Izutsu; Yusuke Sato; Yasunori Ohta; Junichi Furuta; Seiichi Shimizu; Takuya Komeno; Yuji Sato; Takayoshi Ito; Masayuki Noguchi; Emiko Noguchi; Masashi Sanada; Kenichi Chiba; Hiroko Tanaka; Kazumi Suzukawa; Toru Nanmoku; Yuichi Hasegawa; Osamu Nureki; Satoru Miyano; Naoya Nakamura; Kengo Takeuchi; Seishi Ogawa; Shigeru Chiba
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 41.307

10.  Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.

Authors:  Teresa Palomero; Lucile Couronné; Hossein Khiabanian; Mi-Yeon Kim; Alberto Ambesi-Impiombato; Arianne Perez-Garcia; Zachary Carpenter; Francesco Abate; Maddalena Allegretta; J Erika Haydu; Xiaoyu Jiang; Izidore S Lossos; Concha Nicolas; Milagros Balbin; Christian Bastard; Govind Bhagat; Miguel A Piris; Elias Campo; Olivier A Bernard; Raul Rabadan; Adolfo A Ferrando
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 41.307
View more
  11 in total

1.  The Genetic Basis of Hepatosplenic T-cell Lymphoma.

Authors:  Matthew McKinney; Andrea B Moffitt; Philippe Gaulard; Marion Travert; Laurence De Leval; Alina Nicolae; Mark Raffeld; Elaine S Jaffe; Stefania Pittaluga; Liqiang Xi; Tayla Heavican; Javeed Iqbal; Karim Belhadj; Marie Helene Delfau-Larue; Virginie Fataccioli; Magdalena B Czader; Izidore S Lossos; Jennifer R Chapman-Fredricks; Kristy L Richards; Yuri Fedoriw; Sarah L Ondrejka; Eric D Hsi; Lawrence Low; Dennis Weisenburger; Wing C Chan; Neha Mehta-Shah; Steven Horwitz; Leon Bernal-Mizrachi; Christopher R Flowers; Anne W Beaven; Mayur Parihar; Lucile Baseggio; Marie Parrens; Anne Moreau; Pierre Sujobert; Monika Pilichowska; Andrew M Evens; Amy Chadburn; Rex K H Au-Yeung; Gopesh Srivastava; William W L Choi; John R Goodlad; Igor Aurer; Sandra Basic-Kinda; Randy D Gascoyne; Nicholas S Davis; Guojie Li; Jenny Zhang; Deepthi Rajagopalan; Anupama Reddy; Cassandra Love; Shawn Levy; Yuan Zhuang; Jyotishka Datta; David B Dunson; Sandeep S Davé
Journal:  Cancer Discov       Date:  2017-01-25       Impact factor: 39.397

2.  Myo9b is a key player in SLIT/ROBO-mediated lung tumor suppression.

Authors:  Ruirui Kong; Fengshuang Yi; Pushuai Wen; Jianghong Liu; Xiaoping Chen; Jinqi Ren; Xiaofei Li; Yulong Shang; Yongzhan Nie; Kaichun Wu; Daiming Fan; Li Zhu; Wei Feng; Jane Y Wu
Journal:  J Clin Invest       Date:  2015-11-03       Impact factor: 14.808

3.  Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma.

Authors:  Assunta De Rienzo; Michael A Archer; Beow Y Yeap; Nhien Dao; Daniele Sciaranghella; Antonios C Sideris; Yifan Zheng; Alexander G Holman; Yaoyu E Wang; Paola S Dal Cin; Jonathan A Fletcher; Renee Rubio; Larry Croft; John Quackenbush; Peter E Sugarbaker; Kiara J Munir; Jesse R Battilana; Corinne E Gustafson; Lucian R Chirieac; Soo Meng Ching; James Wong; Liang Chung Tay; Stephen Rudd; Robert Hercus; David J Sugarbaker; William G Richards; Raphael Bueno
Journal:  Cancer Res       Date:  2015-11-10       Impact factor: 12.701

4.  TET proteins and the control of cytosine demethylation in cancer.

Authors:  Laurianne Scourzic; Enguerran Mouly; Olivier A Bernard
Journal:  Genome Med       Date:  2015-01-29       Impact factor: 11.117

Review 5.  The RhoA-ROCK pathway in the regulation of T and B cell responses.

Authors:  Edd Ricker; Luvana Chowdhury; Woelsung Yi; Alessandra B Pernis
Journal:  F1000Res       Date:  2016-09-12

Review 6.  Mutational heterogeneity of angioimmunoblastic T-cell lymphoma indicates distinct lymphomagenic pathways.

Authors:  Mathijs Willemsen; Myrurgia Abdul Hamid; Bjorn Winkens; Axel Zur Hausen
Journal:  Blood Cancer J       Date:  2018-01-17       Impact factor: 11.037

7.  Whole-blood dysregulation of actin-cytoskeleton pathway in adult spinal muscular atrophy patients.

Authors:  Jennifer J Siranosian; Flavia C Nery; Christiano R R Alves; Benjamin A Siranosian; Nicholas J Lyons; Eric J Eichelberger; Reid Garner; Salomé Da Silva Duarte Lepez; Alec J Johnstone; Aravind Subramanian; Kathryn J Swoboda
Journal:  Ann Clin Transl Neurol       Date:  2020-06-17       Impact factor: 4.511

Review 8.  Spatiotemporal Control of Intracellular Membrane Trafficking by Rho GTPases.

Authors:  Monilola A Olayioye; Bettina Noll; Angelika Hausser
Journal:  Cells       Date:  2019-11-21       Impact factor: 6.600

9.  Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.

Authors:  M O'Hayre; A Inoue; I Kufareva; Z Wang; C M Mikelis; R A Drummond; S Avino; K Finkel; K W Kalim; G DiPasquale; F Guo; J Aoki; Y Zheng; M S Lionakis; A A Molinolo; J S Gutkind
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

10.  Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma.

Authors:  Edd Ricker; Akanksha Verma; Rossella Marullo; Sanjay Gupta; Chao Ye; Tania Pannellini; Michela Manni; Wayne Tam; Giorgio Inghirami; Olivier Elemento; Leandro Cerchietti; Alessandra B Pernis
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.